In this issue:
Exercise and education vs saline injections for knee OA
Adalimumab introduction vs MTX dose escalation in inadequately controlled PsA
MTX monotherapy vs MTX plus leflunomide in PsA
Immunogenicity of COVID-19 mRNA vaccine in adolescents with JIA on TNFi treatment
Corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection
COVID-19 vaccination and arthritis flare in RA
TLC599 in patients with OA of the knee
Nintedanib in patients with SSc-ILD
Analysing cord blood levels of TNFis to validate the EULAR points to consider
Recreational physical activity and risk of incident knee OA
Please login below to download this issue (PDF)